Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer
Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the maximum-tolerated dose (MTD) of sodium selenite
when administered in combination with radiation therapy to subjects with metastatic cancer
based on safety and tolerability.